Xiaoyan Ding Selected Research

Aquaporin 6

4/2016

Expression of AQP6 and AQP8 in epithelial ovarian tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyan Ding Research Topics

Disease

15	Neoplasms (Cancer) 07/2022 - 09/2003
8	Choroidal Neovascularization 01/2021 - 01/2008
7	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 01/2018
7	Familial Exudative Vitreoretinopathies 03/2022 - 12/2014
7	Retinal Detachment (Retinal Detachments) 01/2022 - 03/2003
6	Pre-Eclampsia (Preeclampsia) 12/2015 - 01/2014
5	Infections 12/2021 - 09/2010
5	Macular Degeneration (Age-Related Maculopathy) 01/2017 - 04/2008
4	Carcinogenesis 01/2022 - 12/2010
4	Inflammation (Inflammations) 01/2017 - 01/2009
4	Breast Neoplasms (Breast Cancer) 11/2015 - 09/2003
3	Neoplasm Metastasis (Metastasis) 07/2022 - 08/2012
3	Body Weight (Weight, Body) 05/2022 - 01/2015
3	Mitochondrial Diseases (Mitochondrial Disease) 05/2022 - 10/2015
3	Toxocariasis 01/2022 - 01/2021
3	Retinoschisis (Retinoschisis, Juvenile) 11/2021 - 08/2012
3	Atrophy 10/2020 - 01/2008
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2018 - 01/2012
3	Triple Negative Breast Neoplasms 04/2017 - 11/2015
3	Neovascular Glaucoma 01/2016 - 06/2013
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2015 - 01/2014
2	Blindness (Hysterical Blindness) 03/2022 - 08/2009
2	COVID-19 02/2022 - 06/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2021
2	Hypertension (High Blood Pressure) 01/2022 - 05/2015
2	Uveitis 01/2022 - 04/2008
2	Granuloma 01/2022 - 10/2021
2	Tuberculosis (Tuberculoses) 12/2021 - 01/2018
2	Disease Progression 10/2021 - 08/2009
2	Refractive Errors (Refractive Error) 01/2021 - 06/2013
2	Fibrosis (Cirrhosis) 01/2021 - 11/2018
2	Liver Neoplasms (Liver Cancer) 01/2020 - 01/2018
2	Glaucoma 01/2019 - 09/2009
2	Hypoxia (Hypoxemia) 10/2016 - 12/2008
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 10/2016 - 10/2016
2	Pathologic Processes 10/2016 - 03/2013
2	Adenomyosis 12/2010 - 10/2010
2	Endometriosis 12/2010 - 10/2010
1	Fatigue 06/2022
1	Norrie disease 03/2022
1	Adenocarcinoma of Lung 02/2022

Drug/Important Bio-Agent (IBA)

18	Retinaldehyde (Retinal)IBA 06/2022 - 01/2008
11	Proteins (Proteins, Gene)FDA Link 05/2022 - 09/2003
8	Pharmaceutical PreparationsIBA 01/2022 - 05/2011
7	Sorafenib (BAY 43-9006)FDA Link 07/2022 - 05/2011
6	Messenger RNA (mRNA)IBA 01/2022 - 09/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2009
6	Fatty Acids (Saturated Fatty Acids)IBA 12/2015 - 08/2009
5	CytokinesIBA 02/2022 - 10/2016
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2010
4	Ranibizumab (Lucentis)FDA Link 01/2021 - 01/2016
4	arginine methyl esterIBA 12/2015 - 01/2014
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2022 - 01/2016
3	lenvatinibIBA 01/2022 - 10/2021
3	LipopolysaccharidesIBA 12/2015 - 01/2014
3	3-Hydroxyacyl-CoA DehydrogenaseIBA 10/2015 - 01/2014
3	VaccinesIBA 01/2013 - 09/2010
2	Cysteine (L-Cysteine)FDA Link 03/2022 - 01/2019
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	Circular RNAIBA 01/2022 - 01/2020
2	Tuberculin (PPD)IBA 12/2021 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2013
2	Fluorescein (Funduscein)FDA LinkGeneric 09/2020 - 12/2017
2	Interleukin-2 (IL2)IBA 01/2020 - 01/2018
2	ClaudinsIBA 01/2019 - 01/2014
2	Indicators and Reagents (Reagents)IBA 04/2017 - 11/2016
2	ChemokinesIBA 01/2016 - 12/2008
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2015 - 01/2012
2	Bevacizumab (Avastin)FDA Link 06/2013 - 05/2011
2	AntibodiesIBA 01/2013 - 09/2010
2	fludarabineIBA 09/2010 - 02/2008
1	BilirubinIBA 07/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2022
1	AlbuminsIBA 07/2022
1	NLR ProteinsIBA 05/2022
1	Uric Acid (Urate)IBA 05/2022
1	NF-kappa B (NF-kB)IBA 05/2022
1	Cathepsin BIBA 02/2022
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 02/2022
1	Methylenetetrahydrofolate Dehydrogenase (NADP) (Dehydrogenase, Methylenetetrahydrofolate)IBA 02/2022
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 02/2022
1	Angiotensin-Converting Enzyme 2IBA 02/2022
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 02/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Interleukin-5 (Interleukin 5)IBA 01/2022
1	sintilimabIBA 01/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	CateninsIBA 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	camrelizumabIBA 01/2022
1	Interleukin-13IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022

Therapy/Procedure

7	Therapeutics 07/2022 - 08/2009
7	Lasers (Laser) 10/2021 - 12/2010
4	Aftercare (After-Treatment) 01/2021 - 02/2009
3	Drug Therapy (Chemotherapy) 02/2022 - 02/2008
3	Vitrectomy 01/2020 - 03/2003
2	Intraperitoneal Injections 11/2018 - 10/2015
2	Intravitreal Injections 01/2016 - 06/2013